NCT04771156View on ClinicalTrials.gov

Ketorolac in Palatoplasty

PHASE4RecruitingINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

September 17, 2021

Primary Completion Date

January 1, 2026

Study Completion Date

January 31, 2026

Conditions
Cleft Lip and Palate
Interventions
DRUG

Ketorolac

Ketorolac 0.5mg/kg will be administered intra-operatively at the conclusion of the case and 3 more doses scheduled every 8 hours in the first 24 hours post-operatively for a total of 4 doses of Ketorolac

DRUG

Placebo

0.9% Normal Saline will be administered intra-operatively at the conclusion of the case and 3 more doses scheduled every 8 hours in the first 24 hours post-operatively for a total of 4 doses of normal saline.

Trial Locations (1)

77030

RECRUITING

The University of Texas Health Science Center at Houston, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER